House Committee on Oversight and Reform

Opioids

More on Opioids

Director of White House Office of National Drug Control Policy to Testify at Oversight Committee Hearing on Federal Response to the Overdose and Addiction Crisis

Jun 24, 2022 Press Release

McKinsey & Company’s Conduct and Conflicts at the Heart of the Opioid Epidemic

Apr 27, 2022 Hearing

Oversight Committee to Hold Hearing on McKinsey & Company’s Key Role in Nation’s Opioid Epidemic

Apr 22, 2022 Press Release

Committee Releases Report Uncovering Significant Conflicts of Interest at McKinsey & Co. Related to Work for FDA and Opioid Manufacturers

Apr 13, 2022 Press Release

Oversight Committee Urges DOJ and Treasury to Examine Tax Benefits Claimed by Opioid Companies for $26 Billion Settlement

Mar 14, 2022 Press Release

Chairwoman Maloney and Rep. DeSaulnier Statements on Sackler Immunity in New Purdue Pharma Settlement

Mar 3, 2022 Press Release

Chairwoman Maloney and Rep. DeSaulnier Statements on Federal Court Rejecting Bankruptcy Settlement for Members of the Sackler Family

Dec 16, 2021 Press Release

Oversight Committee Launches Investigation into McKinsey & Company’s Consulting Practices, Conflicts of Interest

Nov 5, 2021 Press Release

Cooper’s Anti-Sackler Bill Would Keep the Names of Corrupt Individuals Off Public Institutions

Oct 29, 2021 Press Release

Maloney, DeSaulnier, Warren, and Blumenthal Applaud U.S. Trustee Appeal of Purdue Pharma Bankruptcy Plan

Sep 16, 2021 Press Release

Pages